Immunoprecise Antibodies Ltd (IPA) — Financial Flexibility Index
Immunoprecise Antibodies Ltd (IPA) has a Financial Flexibility Index of -0.04x as of April 2025. Free cash flow of $-781.00K (operating CF $-1.14 Million minus capex $359.00K) represents 0% of total liabilities ($20.82 Million). Check IPA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunoprecise Antibodies Ltd Financial Flexibility Index (1997–2025)
Historical Financial Flexibility Index trend for Immunoprecise Antibodies Ltd across 29 annual periods. For the full cash flow conversion analysis, see Immunoprecise Antibodies Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Immunoprecise Antibodies Ltd (1997–2025)
Year-by-year free cash flow to debt coverage for Immunoprecise Antibodies Ltd. Explore cash flow to debt ratio of Immunoprecise Antibodies Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-5.61 Million | $-6.41 Million | $20.82 Million | ▼ -146.6% |
| 2024 | -0.11x | $-2.85 Million | $-4.25 Million | $26.07 Million | ▲ +88.1% |
| 2023 | -0.92x | $-18.34 Million | $-19.83 Million | $20.01 Million | ▼ -92.6% |
| 2022 | -0.48x | $-8.66 Million | $-9.92 Million | $18.21 Million | ▼ -677.4% |
| 2021 | 0.08x | $827.00K | $-600.00K | $10.04 Million | ▲ +223.0% |
| 2020 | -0.07x | $-815.65K | $-1.39 Million | $12.18 Million | ▲ +73.1% |
| 2019 | -0.25x | $-2.56 Million | $-3.21 Million | $10.28 Million | ▲ +3.6% |
| 2018 | -0.26x | $-3.07 Million | $-3.42 Million | $11.87 Million | ▼ -13.4% |
| 2017 | -0.23x | $-190.90K | $-721.65K | $836.91K | ▼ -135.7% |
| 2016 | 0.64x | $301.57K | $284.09K | $472.15K | ▲ +1130.0% |
| 2015 | -0.06x | $-15.79K | $-36.11K | $254.64K | ▲ +59.6% |
| 2014 | -0.15x | $-46.60K | $-46.60K | $303.50K | ▼ -840.9% |
| 2013 | -0.02x | $-4.33K | $-4.33K | $265.63K | ▲ +97.3% |
| 2012 | -0.62x | $-131.08K | $-132.72K | $213.10K | ▼ -1.6% |
| 2011 | -0.61x | $-66.73K | $-80.39K | $110.21K | ▼ -513.9% |
| 2010 | 0.15x | $14.32K | $-308.49K | $97.87K | ▼ -98.2% |
| 2009 | 8.18x | $1.23 Million | $-155.68K | $150.84K | ▲ +173.2% |
| 2008 | -11.17x | $-418.41K | $-523.45K | $37.46K | ▼ -402.6% |
| 2007 | 3.69x | $1.53 Million | $-297.31K | $413.69K | ▼ -70.5% |
| 2006 | 12.53x | $1.74 Million | $-110.59K | $138.62K | ▼ -24.0% |
| 2005 | 16.48x | $777.57K | $-82.20K | $47.18K | ▲ +957.4% |
| 2004 | 1.56x | $77.81K | $-178.69K | $49.92K | ▲ +342.9% |
| 2003 | -0.64x | $-18.95K | $-168.38K | $29.53K | ▲ +55.6% |
| 2002 | -1.45x | $-271.35K | $-280.23K | $187.72K | ▼ -287.2% |
| 2001 | 0.77x | $692.26K | $-8.13K | $896.75K | ▲ +114.4% |
| 2000 | -5.37x | $-54.30K | $-208.54K | $10.11K | ▼ -217.0% |
| 1999 | 4.59x | $164.24K | $-202.94K | $35.78K | ▼ -63.7% |
| 1998 | 12.65x | $852.70K | $-226.81K | $67.39K | ▲ +668.4% |
| 1997 | 1.65x | $411.71K | $-108.20K | $250.04K | — |